Another Investigation Revealing Monopolistic PBM Behavior Receives Industry’s Support
Meanwhile, The PBM Association Calls Again For ‘Balanced Discussion’
While a recent FTC probe revealed PBM practices that block access to generics and biosimilars, a new report by the US House Committee shows that the three big PBMs may seek a safe harbor in foreign countries to avoid scrutiny.
